These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14440189)

  • 1. Investigations in malignant lymphomas.
    RUNDLES RW; LUKES R; ACKERMAN L; HOLLAND J; SPEAR P; SCOTT JL; SPURR CL
    Natl Cancer Inst Monogr; 1960 Aug; 3():193-227. PubMed ID: 14440189
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy of the malignant lymphomas and leukemias.
    GAMBLE JF
    Med Ann Dist Columbia; 1962 Apr; 31():195-9. PubMed ID: 13896557
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of cancers and malignant lymphomas with massive chemotherapy and marrow transplants].
    MEZA C; LARRAIN C; OBERHAUSER E; ASALGADO N
    Rev Med Chil; 1962 Apr; 90():328-35. PubMed ID: 14473235
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of mannitol mustard, cyclophosphamide, and nitrogen mustard in malignant lymphomas.
    LASZLO J; GRIZZLE J; JONSSON U; RUNDLES RW
    Cancer Chemother Rep; 1962 Feb; 16():247-50. PubMed ID: 14462650
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical use of epoxypiperazine, a new alkylating agent, in the treatment of lymphomas and other neoplasms.
    MILLER DG; DIAMOND HD; CRAVER LF
    Cancer Res; 1959 Dec; 19():1204-9. PubMed ID: 14422486
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects on the marrow of chemotherapy, used for the treatment of lymphomas and leukaemias.
    MADIGAN J; MOTTERAM R
    Acta Unio Int Contra Cancrum; 1959; 15(Suppl 1)():194-5. PubMed ID: 14419682
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with a new alkylating agent AB-132, in the treatment of lymphomas and leukemias.
    STUTZMAN L; RAZIS DV; SOKAL JE; AMBRUS JL; ROSS CA
    Cancer Chemother Rep; 1962 May; 18():31-5. PubMed ID: 13918060
    [No Abstract]   [Full Text] [Related]  

  • 8. [Outlines of medical cancerology. 2. Lymphomas. General plan for directing the treatment].
    SILVA MS
    Rev Bras Cir; 1960 May; 39():391-403. PubMed ID: 14446717
    [No Abstract]   [Full Text] [Related]  

  • 9. The chemotherapy of lymphomas.
    DIAMOND HD
    N Y State J Med; 1961 Mar; 61():871-8. PubMed ID: 13722602
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of leukemia, lymphoma, and other malignant neoplasms with Vinblastine.
    HILL JM; LOEB E
    Cancer Chemother Rep; 1961 Dec; 15():41-61. PubMed ID: 13907352
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy in leukemia and malignant reticulosis].
    ARIENS EJ
    Ned Tijdschr Geneeskd; 1959 Sep; 103():1919-22. PubMed ID: 13794222
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic spectrum of uracil-mustard, a new oral antitumor drug. With special reference to the effects of small dosage in lymphomas, chronic leukemias, and ovarian carcinoma.
    SHANBROM E; MILLER S; HAAR H; OPFELL R
    JAMA; 1960 Nov; 174():1702-5. PubMed ID: 13750663
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our experiences with the treatment of malignant lymphomas].
    LIBANSKY J; BRABEC V; CHUDOMEL V; SVOBODA M; SOCHMAN J
    Cas Lek Cesk; 1959 Oct; 98():1284-93. PubMed ID: 14416683
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclophosphamide therapy. Its use in leukemia, lymphoma and solid tumors.
    WALL RL; CONRAD FG
    Arch Intern Med; 1961 Sep; 108():456-82. PubMed ID: 13782776
    [No Abstract]   [Full Text] [Related]  

  • 15. Uracil mustard, a new alkylating agent for oral administration in the management of patients with leukemia and lymphoma.
    KENNEDY BJ; THEOLOGIDES A
    N Engl J Med; 1961 Apr; 264():790-3. PubMed ID: 13752496
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bilateral neoplasms of the orbit with lymphatic type elements treated with antimitotic agents (Endoxan)].
    BERTONCINI G; PARDUCCI F
    Ann Ottalmol Clin Ocul; 1961 Dec; 87():763-74. PubMed ID: 13868478
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of cancers and malignant lymphomas with massive chemotherapy and marrow transplant].
    MEZA ARRAU C; LARAIN C; OBERHAUSER E; ASALGADO N
    Sangre (Barc); 1962; 7():33-54. PubMed ID: 14473234
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and haematological observations in lymphoma patients (Hodgkin's disease, Brill-Symmer's disease, lymphogenous leukaemia) treated with N N Di-2-chloroethyl gamma-P-aminophenyl butiric acid (amboclorin).
    PERRONE V; FAIELLA A; ZARRILLI D; CAJANO A
    Acta Unio Int Contra Cancrum; 1960; 16():907-9. PubMed ID: 14432002
    [No Abstract]   [Full Text] [Related]  

  • 19. Uric acid excretion in patients with malignant lymphomas.
    PRIMIKIRIOS N; STUTZMAN L; SANDBERG AA
    Blood; 1961 Jun; 17():701-18. PubMed ID: 13738036
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiation therapy and adjunctive chemotherapy in the treatment of lymphomas.
    KRABBENHOFT KL
    Am J Roentgenol Radium Ther Nucl Med; 1960 Oct; 84():775-7. PubMed ID: 13753843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.